2012
DOI: 10.1007/s13238-012-2043-4
|View full text |Cite
|
Sign up to set email alerts
|

Mitochondria in the pathogenesis of diabetes: a proteomic view

Abstract: Diabetes mellitus is a complex metabolic disorder characterized by chronic hyperglycemia due to absolute or relative lack of insulin. Though great efforts have been made to investigate the pathogenesis of diabetes, the underlying mechanism behind the development of diabetes and its complications remains unexplored. Cumulative evidence has linked mitochondrial modification to the pathogenesis of diabetes and its complications and they are also observed in various tissues affected by diabetes. Proteomics is an a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
23
0

Year Published

2012
2012
2021
2021

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 27 publications
(25 citation statements)
references
References 104 publications
2
23
0
Order By: Relevance
“…Cumulative evidence has linked altered energy metabolism and mitochondrial modification to the pathogenesis of diabetes and its complications (74). In this sense, proteomic efforts in different tissues from mouse models of type 1 diabetes (T1DM) detected increased expression of several mitochondrial proteins related to FAO, TCA cycle and oxidative stress (75,76).…”
Section: Figmentioning
confidence: 99%
“…Cumulative evidence has linked altered energy metabolism and mitochondrial modification to the pathogenesis of diabetes and its complications (74). In this sense, proteomic efforts in different tissues from mouse models of type 1 diabetes (T1DM) detected increased expression of several mitochondrial proteins related to FAO, TCA cycle and oxidative stress (75,76).…”
Section: Figmentioning
confidence: 99%
“…Along with physiological signal mediators, ECVs appear as potential new tools for clinical diagnostics and may be useful in novel treatment modalities (Lima et al, 2009; Chen et al, 2012). Several groups are currently looking at ECVs as potential carriers of therapeutic drugs or molecules that would down-regulate toxic proteins or elicit an anti-tumor immune response when encapsulating specific siRNAs or adeno-associated viral vectors (Alvarez-Erviti et al, 2011; Maguire et al, 2012).…”
Section: Introductionmentioning
confidence: 99%
“…SM uptakes more than 80% of human body glucose in an insulin‐sensitive manner, thus playing a major role in the development of peripheral and whole body IR . Impaired insulin‐dependent glucose uptake in SM contributes significantly to the pathogenesis of T2D and the metabolic syndrome . Muscle IR has been associated with increased intramyocellular lipid content, contractile weakness, reduced mitochondrial mass, and a decline in crucial ATP‐dependent cellular processes .…”
Section: Mitochondrial Proteomics Targeting Metabolic Tissuesmentioning
confidence: 99%